Osphos is the one FDA authorised intramuscular bisphosphonate injection to the Charge of the scientific symptoms linked to navicular syndrome in horses. This very early response is probably not an indication in the long-term effectiveness from the medication (it might be impartial of the leading, bone modifying consequences). In the situation of